Theranos President Leaves as Blood-Test Startup Adds 3 Directors
- Former Amgen executive Bonanni, Foege, Kovacevich join board
- Balwani retires after serving as chief operating officer
This article is for subscribers only.
Theranos Inc.’s president is leaving the blood-testing startup as the company reconfigures its board, adding a former Amgen Inc. executive and two others as directors.
Sunny Balwani, who also was chief operating officer and a board member, will “support the transition process” as Palo Alto, California-based Theranos seeks to fill “multiple executive positions,” according to a company statement on Wednesday.